Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evotec Se (EVOTF)

Evotec Se (EVOTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 67.93
  • Price/Book 2.64
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.0100 unch
on 11/04/25
8.3600 -4.19%
on 10/27/25
+0.7350 (+10.10%)
since 09/16/25
3-Month
7.0500 +13.62%
on 08/22/25
8.3600 -4.19%
on 10/27/25
-0.5057 (-5.94%)
since 07/18/25

Most Recent Stories

More News
Evotec Enters a Drug Discovery Collaboration with Janssen

HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen...

EVT : 24.95 (+0.04%)
EVOTF : 8.0100 (-1.11%)
EVO : 3.11 (-0.64%)
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology

HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global biopharmaceutical...

EVT : 24.95 (+0.04%)
ALM : 9.47 (+0.32%)
EVOTF : 8.0100 (-1.11%)
EVO : 3.11 (-0.64%)
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

- STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE - DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES - SUBSTANTIALLY...

EVOTF : 8.0100 (-1.11%)
EVO : 3.11 (-0.64%)
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

- THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB - EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A STRATEGIC...

EVOTF : 8.0100 (-1.11%)
EVO : 3.11 (-0.64%)
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic

- EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT IMMUNOMODULATORY...

EVT : 24.95 (+0.04%)
EVOTF : 8.0100 (-1.11%)
EVO : 3.11 (-0.64%)

Business Summary

Evotec AG was incorporated on December 8, 1993.as Evotec BioSystems GmbH. The Company offers drug research, development, and manufacturing services. It provides integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry. The Company provides solutions to the pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 8.0100
2nd Resistance Point 8.0100
1st Resistance Point 8.0100
Last Price 8.0100
1st Support Level 8.0100
2nd Support Level 8.0100
3rd Support Level 8.0100

See More

52-Week High 8.5800
Last Price 8.0100
Fibonacci 61.8% 7.9955
Fibonacci 50% 7.8150
Fibonacci 38.2% 7.6345
52-Week Low 7.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar